✦ LIBER ✦

6508 A randomized phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer (AGC): a preliminary safety results

✍ Scribed by Yun, J.A.; Kong, J.H.; Kim, J.A.; Lee, S.H.; Lee, J.Y.; Park, S.H.; Park, J.O.; Park, Y.S.; Lim, H.Y.; Kang, W.K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomised phase II study of combinati

✍ Jina Yun; Jeeyun Lee; Se Hoon Park; Joon Oh Park; Young Suk Park; Ho Yeong Lim; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 180 KB

A phase II study of epirubicin, cisplati

✍ Kenneth Villman; John F. Öhd; Elisabet Lidbrink; Lena Malmberg; Birgitta Lindh; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 339 KB

Phase I/II study of a combination of doc

✍ Yoon-Koo Kang; Min-Hee Ryu; Changhoon Yoo; Heung-Moon Chang; Jeong Hwan Yook; Su 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 334 KB

A phase II study of capecitabine and doc

✍ Park, Y H; Ryoo, B-Y; Choi, S-J; Kim, H-T 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 98 KB

8574 A phase II study of combination che

✍ Won, Y.W.; Park, Y.H.; Ahn, M.J.; Park, K. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

224 Docetaxel and cisplatin combination

✍ J. Fahlke; K. Ridwelski; E. Kettner; U. Keilholz; C. Schmidt; K. Eichelmann; H. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 160 KB